The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease

April 26, 2022 updated by: Samantha Harrison, Teesside University

An Investigation of the Relationship of Pain With Balance and Gait Impairment in People With Chronic Obstructive Pulmonary Disease

The balance, gait and pain in Chronic Obstructive Pulmonary Disease (COPD) study will aim to investigate the link between balance and gait impairment, and high rates of pain in people with COPD. This cross-sectional observational study will compare balance and gait outcomes for people with COPD who have pain, to those who are pain free.

Study Overview

Study Type

Observational

Enrollment (Actual)

43

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Middlesbrough, United Kingdom, TS4 3BW
        • South Tees Hospitals NHS Trust
      • Stockton-on-Tees, United Kingdom, TS19 8PE
        • North Tees Hospitals NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

People with COPD referred to, or attending, Pulmonary Rehabilitation at local National Health Service Hospitals/Clinics

Description

Inclusion Criteria:

  • Have a spirometry confirmed diagnosis of COPD as per Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
  • Be 18 years or over at the point of recruitment
  • Be able to communicate with good verbal English or use adaptive equipment to communicate.
  • Be able to complete test procedures
  • Stable COPD (six weeks clear of exacerbation)
  • No uncorrected visual or somatosensory disturbance

Exclusion Criteria:

  • No other conditions that may affect balance or gait e.g. neurological or vestibular conditions
  • Recent exacerbation of COPD (within the last six weeks)
  • Unable to provide written informed consent
  • Unable to speak English or no translation options available
  • Any other acute health conditions that would make activity unsafe e.g. acute infection, unstable cardiac disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
COPD with pain
People with COPD who also report pain more often than not over the previous 3 months
Groups are defined by their naturally occurring exposure to pain or not
COPD with no pain
People with COPD who do not report pain more often than not over the previous 3 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance Evaluations Systems Test (BESTest)
Time Frame: 20-30 minutes
BESTest is a quantitative assessment tool that identifies disordered systems underlying postural control that are responsible for poor functional balance. It was developed for clinicians to differentiate balance problems into six underlying systems that may constrain balance. It was developed from the theoretical understanding of balance control systems based on Bernstein's concept that postural control results from a set of interacting systems. It has 36 items that evaluate performance of 6 balance systems: bio-mechanical constraints, stability limits/verticality, anticipatory responses, postural responses, sensory orientation, and stability in gait. A higher score indicates better balance.
20-30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: 5 minutes (for additional items not featured within the BESTest
The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function. A total score of 56 is available, higher scores indicate better balance.
5 minutes (for additional items not featured within the BESTest
Gait analysis
Time Frame: 10 minutes
Temporospatial gait analysis using the 'Gaitrite' walkway.
10 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 second sit to stand test
Time Frame: 30 seconds
The 30 Second Sit to Stand Test is also known as 30 second chair stand test, and tests leg strength and endurance in older adults. A higher number of completed sit to stands in 30 seconds indicates better lower limb endurance.
30 seconds
Peak muscle torque (quadriceps, hamstrings, hip abductors and adductors, ankle plantar flexors and dorsiflexors).
Time Frame: 30 minutes
Muscle strength testing using the Biodex dynamometer. A higher peak torque in Nm indicates better muscle strength.
30 minutes
PiMax
Time Frame: 5 minutes
Maximum inspiratory pressure measured by a hand held device that participants take an inward breath in to.
5 minutes
Brief Pain Inventory Short Form
Time Frame: 5 minutes
The Brief Pain Inventory is a pain questionnaire which measures the severity of pain, impact of pain on daily function, location of pain, pain medications and amount of pain relief in the past 24 hours or the past week. Each item is measured on 0-10 scale, 0 being no pain and 10 being the maximum pain score available.
5 minutes
Physical Activity Scale for the Elderly
Time Frame: 5 minutes
The Physical Activity Scale for the Elderly (PASE) is a questionnaire that combines information on leisure, household and occupational activity. The PASE assesses the types of activities typically chosen by older adults (walking, recreational activities, exercise, housework, yard work, and caring for others. It uses frequency, duration, and intensity level of activity over the previous week to assign a score, ranging from 0 to 793, with higher scores indicating greater physical activity.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Samantha L Harrison, PhD, Teesside University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2019

Primary Completion (Actual)

December 18, 2019

Study Completion (Actual)

December 18, 2019

Study Registration Dates

First Submitted

December 16, 2019

First Submitted That Met QC Criteria

December 16, 2019

First Posted (Actual)

December 18, 2019

Study Record Updates

Last Update Posted (Actual)

April 27, 2022

Last Update Submitted That Met QC Criteria

April 26, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Data will be retained indefinitely in anonymised format and shared on reasonable request

IPD Sharing Time Frame

Once data has been analysed and available indefinitely

IPD Sharing Access Criteria

On request to lead publishing author

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Exposure - pain

Subscribe